Five-year survival for patients with metastatic osteosarcoma is only around 30%.14 We report that pigs with heterozygous and homozygous inactivation of TP53 consistently develop osteosarcomas, providing a new model of osteosarcoma at human scale to understand and treat this devastating disease. Here, TP53 is linked to osteosarcoma.